NCT01689727View on ClinicalTrials.gov

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

September 30, 2004

Conditions
Pituitary Tumors
Interventions
DRUG

Technetium Tc 99m EC20

Trial Locations (1)

Unknown

Emory Hospital, Atlanta

Sponsors

Lead Sponsor

Endocyte
All Listed Sponsors
lead

Endocyte

INDUSTRY

NCT01689727 - Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors | Biotech Hunter | Biotech Hunter